Sobi

Sobi's first-quarter 2026 report says the company kicked off a learning journey for all employees aimed at accelerating smart and responsible use of digital tools, including AI, and that new learning resources and a shared learning channel were launched during the campaign week.

Sobi's capital markets presentation says AI improves physician engagement and supports world-class field-force effectiveness.

Sobi's 2024 annual and sustainability report says the DLBCL, ITP and PNH patient councils co-created AI-driven social media campaigns to empower patients and promote shared decision-making with healthcare professionals.

Under its AI agenda, Sobi's capital markets presentation includes applying data and AI to optimize supply and reduce cost of goods sold.

Sobi's capital markets presentation lists generative-AI authoring of clinical study reports and Module 2 on a map of technology it describes as enabling faster development-cycle time.

On the same technology map, Sobi lists AI-driven disease pathway understanding.

On the same technology map, Sobi lists a literature finder that uses AI beside its real-world-data insights platform.

Sobi says Florio, its rare-disease patient platform, has evolved into a platform generating real-world insights at scale and was co-created with patients and healthcare professionals using design expertise, digital technology and AI.